Adiponectin Positively Correlated With Vascular Resistance in Chronic Heart Failure: Hemodynamic, Echocardiographic Study
Takahiro Ohara(Tohoku Medical and Pharmaceutical University), Masafumi Kitakaze(Hanwa Memorial Hospital), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Akiko Ogai, Masanori Asakura(National Cerebral and Cardiovascular Center), Makoto Amaki(National Cerebral and Cardiovascular Center), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Tohru Funahashi(The University of Osaka), Kazuhiko Hashimura(National Cerebral and Cardiovascular Center)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and Hyperinsulinemia
|The Journal of Clinical Endocrinology & Metabolism|2001|3.4k
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k
Adiponectin and development of type 2 diabetes in the Pima Indian population
|The Lancet|2002|1.1k
Adiponectin, Metabolic Risk Factors, and Cardiovascular Events among Patients with End-Stage Renal Disease
|Journal of the American Society of Nephrology|2002|764